Prevalence of lymphoreticular prion protein accumulation in UK tissue samples

Journal of Pathology

Volumn 203, Issue 3, 2004, Pages 733-739

  Hilton, David A ^a   Ghani, Azra C ^b   Conyers, Lisa ^a   Edwards, Philip ^a   McCardle, Linda ^c   Ritchie, Diane ^c   Penney, Mark ^a   Hegazy, Doha ^a   Ironside, James W ^c  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Creutzfeldt Jakob disease (CJD); Immunohistochemistry; Prion; Screening

Indexed keywords

MONOCLONAL ANTIBODY; PRION PROTEIN;

ADULT; APPENDECTOMY; ARTICLE; BLOOD; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION; INFLAMMATION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RETICULOENDOTHELIAL SYSTEM; SCREENING; SURGICAL INSTRUMENT; TISSUE SECTION; TONSILLECTOMY; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; APPENDECTOMY; APPENDIX; CHILD; CREUTZFELDT-JAKOB SYNDROME; GREAT BRITAIN; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PREVALENCE; PRIONS; TONSIL; TONSILLECTOMY;

EID: 3242716876     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1580     Document Type: Article

References (51)

1. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921 925.
2. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498 501.
3. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383: 685 690.
4. Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448 450.
5. Majeed A, Lehmann P, Kirby L, Knight R, Coleman M. Extent of misclassification of death from Creutzfeldt-Jakob disease in England 1979 96: retrospective examination of clinical records. Br Med J 2000; 320: 145 147.
6. Hillier CE, Salmon RL, Neal JW, Hilton DA. Possible under-ascertainment of variant Creutzfeldt-Jakob disease: a systematic study. J Neurol Neurosurg Psychiatry 2002; 72: 304 309.
7. Anderson RM, Donnelly CA, Ferguson NM, et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996; 382: 779 788.
8. Cousens SN, Vynnycky E, Zeidler M, Will RG, Smith PG. Predicting the CJD epidemic in humans. Nature 1997; 385: 197 198.
9. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Predicted vCJD mortality in Great Britain. Nature 2000; 406: 583 584.
10. d'Aignaux JN, Cousens SN, Smith PG. Predictability of the UK variant Creutzfeldt-Jakob disease epidemic. Science 2001; 294: 1729 1731.
11. Valleron AJ, Boelle PY, Will R, Cesbron JY. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 2001; 294: 1726 1728.
12. Ferguson NM, Ghani AC, Donnelly CA, Hagenaars TJ, Anderson RM. Estimating the human health risk from possible BSE infection of the British sheep flock. Nature 2002; 415: 420 424.
13. Ghani AC, Donnelly CA, Ferguson NM, Anderson RM. Updated projections of future vCJD deaths in the UK. BMC Infect Dis 2003; 3: 4.
14. Lloyd SE, Onwuazor ON, Beck JA, et al. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A 2001; 98: 6279 6283.
15. Anil MH, Love S, Helps CR, et al. Jugular venous emboli of brain tissue induced in sheep by the use of captive bolt guns. Vet Rec 2001; 148: 619 620.
16. Basque PJ, Ryou C, Telling G, et al. Prions in skeletal muscle. Proc Natl Acad Sci U S A 2002; 99: 3812 3817.
17. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001; 358: 171 180.
18. Eklund CM, Kennedy RC, Hadlow WJ. Pathogenesis of scrapie virus infection in the mouse. J Infect Dis 1967; 117: 15 22.
19. Kimberlin RH, Walker CA. Pathogenesis of scrapie in mice after intragastric infection. Virus Res 1989; 12: 213 220.
20. Schreuder BE, van Keulen LJ, Vromans ME, Langeveld JP, Smits MA. Preclinical test for prion diseases. Nature 1996; 381: 563.
21. Bradley R. BSE transmission studies with particular reference to blood. Dev Biol Stand 1999; 99: 35 40.
22. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353: 183 189.
23. Ironside JW, McCardle L, Horsburgh A, Lim Z, Head MW. Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 2002; 110: 79 87.
24. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998; 352: 703 704.
25. Hilton DA, Ghani AC, Conyers L, et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. Br Med J 2002; 325: 633 634.
26. Schreuder BE, van Keulen LJ, Vromans ME, Langeveld JP, Smits MA. Tonsillar biopsy and PrPSc detection in the preclinical diagnosis of scrapie. Vet Rec 1998; 142: 564 568.
27. O'Rourke KI, Baszler TV, Besser TE, et al. Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol 2000; 38: 3254 3259.
28. Ironside JW, Hilton DA, Ghani A, et al. Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet 2000; 355: 1693 1694.
29. Hilton DA. vCJD predicting the future? Neuropathol Appl Neurobiol 2000; 26: 405 407.
30. Sabattini E, Bisgaard K, Ascani S, et al. The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998; 51: 506 511.
31. Muramoto T, Kitamoto T, Tateishi J, Goto I. Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jakob disease via intraperitoneal route: a sequential study. Am J Pathol 1993; 143: 1470 1479.
32. Ford MJ, Burton LJ, Morris RJ, Hall SM. Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 2002; 113: 177 192.
33. Hilton DA, Sutak J, Smith MEF, et al. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 2004; 57: 300 302.
34. Head MW, Ritchie D, Smith N, et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 2004; 164: 143 153.
35. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224 233.
36. Chou I. Strain of unknown prions weighs heavily on Japan, Italy. Nature Med 2003; 9: 1442.
37. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513 529.
38. Korth C, Stierli B, Streit P, et al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 1997; 390: 74 77.
39. Paramithiotis E, Pinard M, Lawton T, et al. A prion protein epitope selective for the pathologically misfolded conformation. Nature Med 2003; 9: 893 899.
40. Race R, Raines A, Raymond GJ, Caughey B, Chesebro B. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J Virol 2001; 75: 10 106 10 112.
41. Asante EA, Linehan JM, Desbruslais M, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002; 21: 6358 6366.
42. Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001; 358: 208 209.
43. Taylor DM, Fraser H, McConnell I, et al. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 1994; 139: 313 326.
44. Brown P, Preece MA, Will RG. 'Friendly fire' in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992; 340: 24 27.
45. Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003; 349: 1812 1820.
46. Kovacs GG, Lindeck-Pozza E, Chimelli L, et al. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle. Ann Neurol 2004; 55: 121 125.
47. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case control study. Lancet 1999; 353: 693 697.
48. Ward HJ, Everington D, Croes EA, et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case control study using community controls. Neurology 2002; 59: 543 548.
49. Hunter N, Foster J, Chong A, et al. Transmission of prion diseases by blood transfusion. J Gen Virol 2002; 83: 2897 2905.
50. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417 421.
51. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 1999; 354: 317 323.